Newsroom

Big Bear Pharmaceutical Announces Trelagliptin and Ivosidenib Approved in Laos

Laos Vientiane-January 03, 2024-BigBear Pharma, a leading alchemon company focus

Laos BigBear Pharmaceuticals successfully obtained GMP certification for traditional medicine processing plant

Laos BigBear Pharmaceuticals successfully obtained GMP certification for traditi

Big Bear Pharmaceutical Announces Selpercatinib Entrectinib and Enasidenib Approved in Laos

Laos Vientiane-October 11, 2023-BigBear Pharma, a leading alchemon company focus

Big Bear Pharmaceutical Announces Pomalidomide and Pemigatinib Approved in Laos

Laos Vientiane-October 10, 2023-BigBear Pharma, a leading alchemon company focusing on development and commercial cancer innovation therapy, announced today that two products have been approved by the

BigBear Pharmaceutical announced that Eltrombopag was approved in Laos

Vientiane, Laos - September 22, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that Cabozantini

Big Bear Pharmaceutical Announces Isazomib, Lenalidomide, Mitotane, Tofacitinib, Tucatinib, Deucravacitinib and Upadatin

Vientiane, Laos - August 22, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that seven products

Lao Food and Drug Administration came to Big Bear Pharma to inspect and guide the traditional medicine factory

VIENTIANE, VIENTIANE, LAO PDR, June 28, 2023 Lao Food and Drug Administration came to Big Bear Pharma to inspect and guide the traditional medicine factory. The investor team of Big Bear Pharmaceutica

BigBear Pharmaceutical announced that Ibrutinib and Erdafitinib were approved in Laos

Vientiane, Laos - August 01, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that two products h

BigBear Pharmaceutical announced that Osimertinib, Mobocertinib, Avatrombopag and Acalabrutinib were approved in Laos

Vientiane, Laos - July 04, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that four products ha

BigBear Pharmaceutical announced that Selinexor, Venetoclax and Sotorasib were approved in Laos

Vientiane, Laos - Jun 08, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that three products ha